Litcius/Paper detail

Routine, Cost-Effective SARS-CoV-2 Surveillance Testing Using Pooled Saliva Limits Viral Spread on a Residential College Campus

Nicole A. Vander Schaaf, Anthony J. Fund, Brianna V. Munnich, Alexi Zastrow, Erin E. Fund, Tanner L. Senti, Abigail F. Lynn, Jonathon J. Kane, Jennifer L. Love, Gregory J. Long, Nicholas J. Troendle, Daniel R. Sharda

2021Microbiology Spectrum27 citationsDOIOpen Access PDF

Abstract

This study highlights the utility of routine testing for SARS-CoV-2 using pooled saliva while maintaining high sensitivity of detection (under 2,500 copies/ml) and rapid turnaround of high volume (up to 930 samples in 8 h by two technicians and one quantitative PCR [qPCR] machine). This pooled approach allowed us to test all residential students 1 to 2 times per week on our college campus during the spring of 2021 and flagged 83% of our semester positives. Most students were asymptomatic or presented with symptoms mirroring common colds at the time of testing, allowing for removal of infectious individuals before they otherwise would have sought testing. To our knowledge, the total per-sample consumable cost of $0.43 is the lowest to date. With many communities still lagging in vaccination rates, routine testing that is cost-efficient highlights the capacity of the laboratory's role in controlling the spread of SARS-CoV-2.

Topics & Concepts

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSalivaFalse positive paradoxMedicineVirologyTurnaround timeOutbreakStatisticsInternal medicineComputer scienceMathematicsInfectious disease (medical specialty)Operating systemDiseaseSARS-CoV-2 detection and testingBiosensors and Analytical DetectionSARS-CoV-2 and COVID-19 Research